Graphic and Report: Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox
Graphic and Report: Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox
Date posted:
May 30, 2023
Last reviewed:
May 30, 2023
Centers for Disease Control and Prevention (CDC)
Graphic presents findings from the the CDC's Morbidity and Mortality Weekly Report (MMWR) indicating that people who received a JYNNEOS vaccine against mpox had significantly reduced risk for infection. The study included vaccine effectiveness results for partial and full vaccination shows that the full 2-dose series offers the best protection. The related MMWR report is available here: Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study | CDC.
Download Resource
Factsheet: Influenza FAQ (English, 33 Other Languages)
Matching terms:
COVID-19 Branded Costs and coverage
Webinar and Tool: Applying an Equity Lens to Decision Making (56:56)
Matching terms:
Branded Document (Text)
Factsheet: Adult Vaccination Insurance Coverage
Matching terms:
Branded Website
Factsheet: Mpox Isolation and Infection Control Guidance to Use at Home
Matching terms:
Factsheet Branded
Toolkit: Encouraging COVID and Flu Vaccinations Among Black, Indigenous, and People of Color (BIPOC) with Disabilities (English, Spanish)
Matching terms:
COVID-19 Unbranded Black/African American
Video: COVID-19 Vaccines are Safe and Effective (0:34) (English, 44 Languages)
Matching terms:
Public Service Announcement COVID-19 Branded Video Multiple Races/Ethnicities Effectiveness